Floatz logo

Pneumococcal Polyvalent Vaccine

Adult Immunoblastic Large Cell Lymphoma

Mayo ClinicvaccineEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Adult Immunoblastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BBB
Fludarabine
University of Medicine and Dentistry of New Jersey
Phase 2BBB
VINCRISTINE SULFATE
University of Chicago
Phase 2BBB
DEXAMETHASONE
Mayo Clinic
Phase 2BBB

View all 50 →

Same molecule, other indications

Pneumococcal Polyvalent Vaccine is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
70 / 100
View asset →
pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →